Skip to Main Content

Paper Details

Personalization of prostate cancer therapy through phosphoproteomics.
Nat Rev Urol
22
2018
Author NameAffiliation
Michael R FreemanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
  • 1 - 1

Datasets

Release 1.2